Tibsovo Alternatives Compared
| Tibsovo (ivosidenib) | Imfinzi (durvalumab) | Durvalumab |
|
|---|
| Tibsovo (ivosidenib) | Imfinzi (durvalumab) | Durvalumab |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Biliary Tract Tumor, Acute Myeloid Leukemia, Myelodysplastic Syndrome. Tibsovo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Non Small Cell Lung Cancer, Small Cell Lung Cancer, Biliary Tract Tumor, Hepatocellular Carcinoma, Bladder Cancer, Endometrial Cancer. Imfinzi may also be used for purposes not listed... View more |
Prescription only
Prescribed for Non Small Cell Lung Cancer, Small Cell Lung Cancer, Biliary Tract Tumor, Hepatocellular Carcinoma, Bladder Cancer, Endometrial Cancer. Durvalumab may also be used for purposes not... View more |
Related suggestions Biliary Tract Tumor
|
|||||||||||||||
| More about Tibsovo (ivosidenib) | More about Imfinzi (durvalumab) | More about Durvalumab | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Imfinzi has an average rating of 8.0 out of 10 from a total of 7 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 0% reported a negative effect. |
Durvalumab has an average rating of 7.5 out of 10 from a total of 8 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Tibsovo side effects |
View all Imfinzi side effects |
View all Durvalumab side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Tibsovo prices |
View all Imfinzi prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
Imfinzi | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
129 hours |
408 hours |
408 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 582 drugs are known to interact with Tibsovo:
|
A total of 628 drugs are known to interact with Imfinzi:
|
A total of 628 drugs are known to interact with Durvalumab:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
July 20, 2018 |
May 01, 2017 |
May 01, 2017 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Ziihera
Ziihera (zanidatamab) is a bispecific HER2-directed antibody used to treat HER2-positive biliary ...
Pemazyre
Pemazyre is used to treat certain types of bile duct cancer and myeloid/lymphoid neoplasms ...
Lytgobi
Lytgobi (futibatinib) is used for the treatment of bile duct cancer (intrahepatic ...
Pemigatinib
Pemigatinib is used for cholangiocarcinoma, myeloid/lymphoid neoplasms
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.